Beurs gesloten -
Japan Exchange
08:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
5.948
JPY
|
+0,93%
|
|
+1,00%
|
+32,95%
|
Fiscaal tijdperk: April |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
313.179
|
213.628
|
215.044
|
205.143
|
198.133
|
208.373
|
-
|
-
|
Bedrijfswaarde
1 |
277.045
|
173.535
|
171.777
|
153.881
|
160.060
|
161.469
|
153.271
|
143.629
|
K/w-verhouding
|
34,7
x
|
23,3
x
|
32,1
x
|
29
x
|
21,5
x
|
20
x
|
19,9
x
|
17,7
x
|
Dividendrendement
|
0,62%
|
0,91%
|
0,91%
|
0,94%
|
1,06%
|
1,03%
|
1,09%
|
1,22%
|
Marktkapitalisatie/omzet
|
1,14
x
|
0,73
x
|
0,72
x
|
0,65
x
|
0,55
x
|
0,53
x
|
0,49
x
|
0,47
x
|
Bedrijfswaarde/omzet
|
1,01
x
|
0,59
x
|
0,58
x
|
0,49
x
|
0,45
x
|
0,41
x
|
0,36
x
|
0,32
x
|
Bedrijfswaarde/EBITDA
|
11,5
x
|
7,08
x
|
8,76
x
|
6,39
x
|
6,19
x
|
5,36
x
|
5,15
x
|
4,48
x
|
Bedrijfswaarde/FCF
|
-53,3
x
|
14,6
x
|
19
x
|
12,6
x
|
19,2
x
|
20,8
x
|
26,2
x
|
19,4
x
|
FCF Yield
|
-1,88%
|
6,87%
|
5,25%
|
7,94%
|
5,21%
|
4,81%
|
3,82%
|
5,16%
|
Price to Book
|
3,02
x
|
1,93
x
|
1,86
x
|
1,72
x
|
1,57
x
|
1,55
x
|
1,45
x
|
1,37
x
|
Aantal aandelen (in duizenden)
|
35.427
|
35.427
|
35.427
|
35.127
|
35.130
|
35.032
|
-
|
-
|
Referentieprijs
2 |
8.840
|
6.030
|
6.070
|
5.840
|
5.640
|
5.948
|
5.948
|
5.948
|
Datum van publicatie
|
4/06/19
|
4/06/20
|
4/06/21
|
3/06/22
|
2/06/23
|
-
|
-
|
-
|
Fiscaal tijdperk: April |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
275.596
|
292.615
|
297.305
|
316.247
|
358.742
|
396.306
|
421.001
|
443.869
|
EBITDA
1 |
24.153
|
24.511
|
19.611
|
24.064
|
25.843
|
30.106
|
29.746
|
32.080
|
Bedrijfsresultaat (EBIT)
1 |
16.067
|
16.068
|
10.932
|
15.139
|
16.004
|
18.630
|
18.641
|
21.094
|
Operationele Marge
|
5,83%
|
5,49%
|
3,68%
|
4,79%
|
4,46%
|
4,7%
|
4,43%
|
4,75%
|
Resultaat voor belastingen (EBT)
1 |
15.624
|
15.930
|
11.767
|
13.125
|
15.882
|
18.763
|
19.805
|
21.443
|
Nettowinst (verlies)
1 |
9.029
|
9.179
|
6.697
|
7.092
|
9.234
|
10.460
|
10.508
|
11.787
|
Nettomarge
|
3,28%
|
3,14%
|
2,25%
|
2,24%
|
2,57%
|
2,64%
|
2,5%
|
2,66%
|
WPA
2 |
254,9
|
259,1
|
189,0
|
201,5
|
262,9
|
297,7
|
299,1
|
335,5
|
Free Cash Flow
1 |
-5.197
|
11.922
|
9.025
|
12.213
|
8.336
|
7.760
|
5.855
|
7.406
|
FCF-marge
|
-1,89%
|
4,07%
|
3,04%
|
3,86%
|
2,32%
|
1,96%
|
1,39%
|
1,67%
|
Kasstroomconversie (ebitda)
|
-
|
48,64%
|
46,02%
|
50,75%
|
32,26%
|
25,78%
|
19,68%
|
23,09%
|
Kasstroomconversie (nettowinst)
|
-
|
129,88%
|
134,76%
|
172,21%
|
90,28%
|
74,19%
|
55,72%
|
62,83%
|
Dividend per aandeel
2 |
55,00
|
55,00
|
55,00
|
55,00
|
60,00
|
61,25
|
65,00
|
72,50
|
Datum van publicatie
|
4/06/19
|
4/06/20
|
4/06/21
|
3/06/22
|
2/06/23
|
-
|
-
|
-
|
Fiscaal tijdperk: April |
2020 S1
|
2021 S1
|
2021 S2
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
2025 Q4
|
---|
Omzet
1 |
145.851
|
145.352
|
151.953
|
77.961
|
152.972
|
81.638
|
81.637
|
81.470
|
89.734
|
171.204
|
92.702
|
94.836
|
-
|
94.654
|
99.073
|
193.727
|
102.633
|
101.736
|
102.273
|
105.167
|
108.871
|
107.209
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
8.354
|
3.927
|
7.005
|
3.165
|
5.776
|
4.438
|
4.925
|
2.753
|
4.031
|
6.784
|
4.901
|
4.319
|
-
|
3.610
|
5.139
|
8.749
|
5.556
|
4.652
|
3.874
|
5.425
|
5.744
|
5.666
|
Operationele Marge
|
5,73%
|
2,7%
|
4,61%
|
4,06%
|
3,78%
|
5,44%
|
6,03%
|
3,38%
|
4,49%
|
3,96%
|
5,29%
|
4,55%
|
-
|
3,81%
|
5,19%
|
4,52%
|
5,41%
|
4,57%
|
3,79%
|
5,16%
|
5,28%
|
5,29%
|
Resultaat voor belastingen (EBT)
1 |
8.439
|
4.524
|
7.243
|
-
|
6.064
|
4.673
|
-
|
2.996
|
4.169
|
7.165
|
4.943
|
3.774
|
-
|
3.942
|
5.485
|
9.427
|
5.604
|
4.959
|
4.099
|
5.650
|
5.969
|
5.891
|
Nettowinst (verlies)
1 |
4.622
|
2.630
|
4.067
|
2.029
|
3.338
|
2.893
|
861
|
1.704
|
2.100
|
3.804
|
2.824
|
2.606
|
-
|
2.140
|
3.117
|
5.257
|
3.473
|
2.173
|
2.292
|
3.159
|
3.337
|
3.293
|
Nettomarge
|
3,17%
|
1,81%
|
2,68%
|
2,6%
|
2,18%
|
3,54%
|
1,05%
|
2,09%
|
2,34%
|
2,22%
|
3,05%
|
2,75%
|
-
|
2,26%
|
3,15%
|
2,71%
|
3,38%
|
2,14%
|
2,24%
|
3%
|
3,07%
|
3,07%
|
WPA
|
130,5
|
74,24
|
-
|
57,58
|
94,68
|
82,21
|
24,58
|
48,53
|
59,77
|
108,3
|
80,40
|
74,17
|
-
|
60,93
|
-
|
149,7
|
98,85
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
55,00
|
-
|
-
|
-
|
-
|
60,00
|
60,00
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
3/12/19
|
3/12/20
|
4/06/21
|
3/12/21
|
3/12/21
|
4/03/22
|
3/06/22
|
2/09/22
|
2/12/22
|
2/12/22
|
3/03/23
|
2/06/23
|
2/06/23
|
1/09/23
|
6/12/23
|
6/12/23
|
1/03/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: April |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
36.134
|
40.093
|
43.267
|
51.262
|
38.073
|
46.904
|
55.102
|
64.744
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-5.197
|
11.922
|
9.025
|
12.213
|
8.336
|
7.760
|
5.855
|
7.406
|
ROE (netto-inkomsten/eigen vermogen)
|
9%
|
8,5%
|
5,9%
|
6%
|
7,5%
|
8,02%
|
7,63%
|
7,98%
|
ROA (netto-inkomsten/totale activa)
|
8,93%
|
8,8%
|
6,37%
|
7,71%
|
7,68%
|
8,05%
|
7,6%
|
8%
|
Totale activa
1 |
101.067
|
104.349
|
105.126
|
91.988
|
120.190
|
129.940
|
138.263
|
147.334
|
Nettoactief per aandeel
2 |
2.931
|
3.131
|
3.267
|
3.386
|
3.599
|
3.834
|
4.101
|
4.350
|
Cashflow per aandeel
2 |
365,0
|
374,0
|
309,0
|
338,0
|
420,0
|
668,0
|
646,0
|
-
|
Capex
1 |
5.449
|
5.825
|
5.903
|
8.913
|
11.931
|
8.497
|
9.270
|
9.620
|
Capex/omzet
|
1,98%
|
1,99%
|
1,99%
|
2,82%
|
3,33%
|
2,14%
|
2,2%
|
2,17%
|
Datum van publicatie
|
4/06/19
|
4/06/20
|
4/06/21
|
3/06/22
|
2/06/23
|
-
|
-
|
-
|
Laatste slotkoers
5.948
JPY Gemiddelde koersdoel
5.370
JPY Spread / Gemiddelde doel -9,72% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +32,95% | 1,32 mld. | | -12,86% | 8,57 mld. | | +6,76% | 419 mln. | | +5,93% | 282 mln. | | +10,56% | 224 mln. | | -8,26% | 85,07 mln. | | -46,83% | 81,99 mln. | | +20,94% | 59,57 mln. |
Detailhandel - Drugs zonder kruidenierswinkel
|